secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stoke Therapeutics, Inc. (STOK)
CIK:        0001623526
Form:       8-K
Filed at:   2026-01-26T23:59:59+00:00
Accession:  0001193125-26-022569
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Stoke Therapeutics enters $85.5M lease for 98,500 sq ft Waltham HQ/lab through 2038
--------------------------------------------------------------------------------

- New lease with NWALP PHOP Property Owner LLC for 98,500 sq ft at 245 Fifth Avenue, Waltham, MA.
- Aggregate base rent ~$85.5M over term ending March 31, 2038; two five-year extension options at market rate.
- Security deposit of $3M in form of irrevocable standby letter of credit, reducible over time.
- Lease supports expansion of corporate headquarters and laboratory space.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1623526/000119312526022569/0001193125-26-022569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1623526/000119312526022569/d100412d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-022569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer